Page last updated: 2024-09-04

phosphorus and paroxetine

phosphorus has been researched along with paroxetine in 3 studies

Compound Research Comparison

Studies
(phosphorus)
Trials
(phosphorus)
Recent Studies (post-2010)
(phosphorus)
Studies
(paroxetine)
Trials
(paroxetine)
Recent Studies (post-2010) (paroxetine)
48,0741,12617,1394,2571,0311,031

Protein Interaction Comparison

ProteinTaxonomyphosphorus (IC50)paroxetine (IC50)
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)3.9
MyeloperoxidaseHomo sapiens (human)0.02
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.086
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.532
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.244
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.123
Quinolone resistance protein NorAStaphylococcus aureus7
Cytochrome P450 2D6Homo sapiens (human)0.5003
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.145
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.179
Beta-adrenergic receptor kinase 1Bos taurus (cattle)1.08
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.093
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.623
Beta-adrenergic receptor kinase 1Homo sapiens (human)1.24
Substance-P receptorHomo sapiens (human)0.9
Sodium-dependent serotonin transporterHomo sapiens (human)0.0007
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.0003
P2X purinoceptor 4Rattus norvegicus (Norway rat)2.45
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)3.9
Sodium-dependent dopamine transporter Homo sapiens (human)0.672
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)3.9
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)3.9
P2X purinoceptor 4Homo sapiens (human)2.8067
Sigma non-opioid intracellular receptor 1Homo sapiens (human)5.366
TransporterRattus norvegicus (Norway rat)0.535

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almarza, E; Martínez, MA; Sánchez de la Torre, C1
Kapoian, T; Ravella, S; Sherman, RA1
Anraku, M; Hirayama, F; Iohara, D; Kadowaki, D; Maruyama, T; Otagiri, M; Shimoishi, K; Uto, A; Zingami, S1

Other Studies

3 other study(ies) available for phosphorus and paroxetine

ArticleYear
A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.
    Journal of analytical toxicology, 2004, Volume: 28, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, Gas; Chromatography, Liquid; Citalopram; Doxepin; Female; Fluvoxamine; Humans; Mianserin; Nitrogen; Paroxetine; Phosphorus; Reproducibility of Results; Trazodone

2004
A dearth of data: the problem of phosphorus in prescription medications.
    Kidney international, 2015, Volume: 87, Issue:6

    Topics: Amlodipine; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Drug Labeling; Drugs, Generic; Humans; Lisinopril; Paroxetine; Phosphorus; Prescription Drugs; Renal Dialysis

2015
A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume: 137, Issue:7

    Topics: Amlodipine; Drugs, Generic; Humans; Japan; Paroxetine; Phosphorus; Phosphorus, Dietary; Prescription Drugs; Renal Dialysis

2017